IGF1 and differentiated thyroid carcinoma: Thyroid follicular cells of patients with differentiated thyroid cancer (DTC) were considered to have a higher number of IGF-1 binding sites, and increased frequency of NRAS codon 61 point mutations was determined in DTC patients with acromegaly [19,20].